FOCUS: Future Of Cancer Genetic testing as Usual and Standard care – breast cancer study

Future Of Cancer Genetic testing as Usual and Standard care – breast cancer study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON24872

Enrollment

400

Registered

2021-09-02

Start date

2019-10-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with (history of) breast cancer and eligible for genetic testing 2. Intervention group: pre-test counseling for germline genetic testing is performed by non-genetic healthcare professional 3. Control group: pre-test counseling for germline genetic testing is performed by genetic healthcare professional.

Exclusion criteria

Exclusion criteria: 1. Patients that receive genetic counseling for predictive genetic testing 2. Unable to understand, speak and write Dutch language 3. For control group: patients that received genetic testing in the past and are eligible for testing of additional genes.

Design outcomes

Primary

Measure	Time frame
acceptability and feasibility for healthcare professionals and patients of a mainstream genetic testing pathway.	—

Secondary

Measure	Time frame
uptake of genetic testing	—

Contacts

Public ContactKyra Bokkers

University Medical Center Utrecht

K.Bokkers@umcutrecht.nl0887553800

Outcome results